SCHEMBL6175490

SCHEMBL6175490

CCN1CCN(C(=O)c2cc(CN3C(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C(=O)C3(C)C)ccn2)CC1

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2939323 0.93 IGF1R (0.57) IGF1R
SCHEMBL2943342 0.91 IGF1R (0.57) IGF1R
SCHEMBL2939598 0.90 IGF1R (0.55) IGF1R
SCHEMBL2935622 0.89 IGF1R (0.56) IGF1R
SCHEMBL2940717 0.86 IGF1R (0.73) IGF1R
SCHEMBL2935470 0.86 IGF1R (0.62) IGF1R
SCHEMBL2937702 0.84 IGF1R (0.46) IGF1R
SCHEMBL2940375 0.84 IGF1R (0.58) IGF1R
SCHEMBL2939900 0.83 IGF1R (0.59) IGF1R
SCHEMBL2942844 0.83 IGF1R (0.74) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed